课题基金 / 基金详情

项目摘要

项目成果

EMANUELA TAIOLI的其他基金

相似基金

相关文献

中文摘要
翻译
项目摘要/摘要-癌症预防和控制(CPC)计划 Tisch癌症研究所(TCI)的癌症预防和控制(CPC)计划由38个 具有共同目标的成员,即减少癌症发病率和死亡率的负担,并改善 癌症患者的生活,重点是TCI Impact集水区的人口。通力合作, 他们研究癌症风险因素、早期检测和筛查以及医疗保健提供。 他们代表20个部门和11个研究所。截至2019年2月,中共计划成员被授予 670万美元的直接成本资金,NCI提供210万美元的支持,以及与癌症相关的同行审查支持 540万美元。2018年,该计划发表了119篇论文,其中34%是内部论文,10%是内部论文 程序化的。 CPC成员进行协作研究,以解决该计划的三个主题:1)风险因素 评估和缓解,2)癌症早期检测和筛查,以及3)医疗保健提供。的目标是 该计划旨在评估和缓解癌症风险因素,并特别关注那些在 在集水区,为高危人群制定有效的早期检测和筛查战略,同时 解决健康差距,并改善受癌症影响的人的护理质量和生活质量 通过医疗保健服务。
英文摘要
PROJECT SUMMARY/ABSTRACT – CANCER PREVENTION AND CONTROL (CPC) PROGRAM The Cancer Prevention and Control (CPC) Program of The Tisch Cancer Institute (TCI) is comprised of 38 members who share a common goal to reduce the burden of cancer incidence and mortality and improve the lives of cancer patients, with emphasis on the population in the impact catchment area of TCI. Collaboratively, they study cancer risk factors, early detection and screening and healthcare delivery. They represent 20 Departments and 11 Institutes. As of February 2019, CPC program members were awarded $6.7 million in direct cost funding, with NCI support of $2.1 million and peer-reviewed cancer related support of $5.4 million. In 2018, the program published 119 papers of which 34% were intra- and 10% were inter- programmatic. CPC members conduct collaborative research that addresses the three themes of the program: 1) Risk Factor Evaluation and Mitigation, 2) Cancer Early Detection and Screening, and 3) Healthcare Delivery. The aims of the program are to evaluate and mitigate cancer risk factors with special attention to those most prevalent in the catchment area, to develop effective early detection and screening strategies for groups at higher risk while addressing health disparities, and to improve the quality of care and quality of life of people affected by cancer through healthcare delivery.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative Core
Administrative Core
1/2- Feasibility study to build a collaboration in genetics and genomic cancer research
1/2- Feasibility study to build a collaboration in genetics and genomic cancer research
海外基金